Aprogen Biologics Statistics

Total Valuation

KRX:003060 has a market cap or net worth of KRW 223.29 billion. The enterprise value is 339.19 billion.

Market Cap	223.29B
Enterprise Value	339.19B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:003060 has 310.99 million shares outstanding. The number of shares has increased by 99.40% in one year.

Current Share Class	n/a
Shares Outstanding	310.99M
Shares Change (YoY)	+99.40%
Shares Change (QoQ)	+16.09%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.05%
Float	198.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.31
PB Ratio	0.59
P/TBV Ratio	0.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.23
EV / Sales	5.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.33

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.41.

Current Ratio	0.78
Quick Ratio	0.38
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	-3.33
Interest Coverage	-10.62

Financial Efficiency

Return on equity (ROE) is -28.09% and return on invested capital (ROIC) is -6.76%.

Return on Equity (ROE)	-28.09%
Return on Assets (ROA)	-6.20%
Return on Invested Capital (ROIC)	-6.76%
Return on Capital Employed (ROCE)	-13.21%
Revenue Per Employee	178.72M
Profits Per Employee	-278.46M
Employee Count	377
Asset Turnover	0.11
Inventory Turnover	1.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.09% in the last 52 weeks. The beta is 0.14, so KRX:003060's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	-41.09%
50-Day Moving Average	751.30
200-Day Moving Average	1,104.48
Relative Strength Index (RSI)	46.03
Average Volume (20 Days)	428,202

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:003060 had revenue of KRW 67.38 billion and -104.98 billion in losses. Loss per share was -835.00.

Revenue	67.38B
Gross Profit	-7.85B
Operating Income	-58.58B
Pretax Income	-104.98B
Net Income	-104.98B
EBITDA	-39.49B
EBIT	-58.58B
Loss Per Share	-835.00

Full Income Statement

Balance Sheet

The company has 38.32 billion in cash and 154.02 billion in debt, giving a net cash position of -115.70 billion or -372.03 per share.

Cash & Cash Equivalents	38.32B
Total Debt	154.02B
Net Cash	-115.70B
Net Cash Per Share	-372.03
Equity (Book Value)	378.69B
Book Value Per Share	1,915.71
Working Capital	-32.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.00 billion and capital expenditures -15.26 billion, giving a free cash flow of -46.26 billion.

Operating Cash Flow	-31.00B
Capital Expenditures	-15.26B
Free Cash Flow	-46.26B
FCF Per Share	-148.75

Full Cash Flow Statement

Margins

Gross margin is -11.64%, with operating and profit margins of -86.94% and -155.81%.

Gross Margin	-11.64%
Operating Margin	-86.94%
Pretax Margin	-155.81%
Profit Margin	-155.81%
EBITDA Margin	-58.60%
EBIT Margin	-86.94%
FCF Margin	n/a

Dividends & Yields

KRX:003060 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-99.40%
Shareholder Yield	-99.40%
Earnings Yield	-47.01%
FCF Yield	-20.72%

Stock Splits

The last stock split was on March 27, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Mar 27, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

KRX:003060 has an Altman Z-Score of -0.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.46
Piotroski F-Score	n/a